Literature DB >> 16341291

Drug-induced catatonia.

Harpreet S Duggal1, Ira Singh.   

Abstract

Catatonia is a heterogeneous syndrome that varies in etiology, presentation, course and sequelae. Initially conceptualized as a subtype of schizophrenia, catatonia is now recognized to occur not only with other psychiatric conditions but also with medical conditions and drug-induced and toxic states. While drug-induced catatonia is now a recognized entity, most studies club it with catatonia due to general medical conditions or organic catatonia, thus precluding any meaningful interpretation of such cases. The literature on drug-induced catatonia mostly draws from scattered case reports. This article attempts to review the available literature in this realm and integrate the information in an attempt to explore the epidemiology, etiology, mechanism and treatment of drug-induced catatonia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16341291     DOI: 10.1358/dot.2005.41.9.899610

Source DB:  PubMed          Journal:  Drugs Today (Barc)        ISSN: 1699-3993            Impact factor:   2.245


  3 in total

1.  Going Back to Kahlbaum's Psychomotor (and GABAergic) Origins: Is Catatonia More Than Just a Motor and Dopaminergic Syndrome?

Authors:  Dusan Hirjak; Katharina M Kubera; R Christian Wolf; Georg Northoff
Journal:  Schizophr Bull       Date:  2020-02-26       Impact factor: 9.306

2.  Resolution of catatonic symptoms: a varied presentation.

Authors:  Nilamadhab Kar; Narasimha Prasad Bhathala Venkata
Journal:  BMJ Case Rep       Date:  2009-10-12

3.  Catatonia associated with initiating paliperidone treatment.

Authors:  Nathanael J McKeown; James H Bryan; B Zane Horowitz
Journal:  West J Emerg Med       Date:  2010-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.